Cubist Systematic Strategies’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $525K | Sell |
67,958
-762,547
| -92% | -$5.34M | ﹤0.01% | 2261 |
|
|
2025
Q2 | $6.07M | Buy |
+830,505
| New | +$6.7M | 0.03% | 897 |
|
|
2024
Q3 | – | Sell |
-104,195
| Closed | -$1.45M | – | 3324 |
|
|
2024
Q2 | $1.45M | Sell |
104,195
-12,837
| -11% | -$182K | 0.01% | 1538 |
|
|
2024
Q1 | $1.84M | Buy |
+117,032
| New | +$1.81M | 0.01% | 1713 |
|
|
2023
Q4 | – | Sell |
-99,136
| Closed | -$1.22M | – | 3918 |
|
|
2023
Q3 | $1.22M | Buy |
99,136
+98,551
| +16,846% | +$1.47M | 0.01% | 1738 |
|
|
2023
Q2 | $9.4K | Buy |
+585
| New | +$9.64K | ﹤0.01% | 3259 |
|
|
2023
Q1 | – | Sell |
-91,672
| Closed | -$847K | – | 4244 |
|
|
2022
Q4 | $847K | Sell |
91,672
-5,488
| -6% | -$51.2K | ﹤0.01% | 2608 |
|
|
2022
Q3 | $837K | Sell |
97,160
-398,077
| -80% | -$3.95M | ﹤0.01% | 2770 |
|
|
2022
Q2 | $4.04M | Buy |
495,237
+335,283
| +210% | +$3.2M | 0.02% | 1184 |
|
|
2022
Q1 | $1.94M | Buy |
159,954
+132,140
| +475% | +$2.78M | 0.02% | 1505 |
|
|
2021
Q4 | $949K | Buy |
+27,814
| New | +$1.09M | 0.01% | 1958 |
|
|
2021
Q3 | – | Sell |
-19,135
| Closed | -$864K | – | 3102 |
|
|
2021
Q2 | $864K | Buy |
19,135
+5,829
| +44% | +$258K | 0.01% | 1683 |
|
|
2021
Q1 | $642K | Buy |
13,306
+7,825
| +143% | +$407K | 0.01% | 1816 |
|
|
2020
Q4 | $295K | Sell |
5,481
-69,705
| -93% | -$3.15M | ﹤0.01% | 2048 |
|
|
2020
Q3 | $2.77M | Buy |
+75,186
| New | +$2.8M | 0.04% | 711 |
|
|
2020
Q1 | – | Sell |
-13,189
| Closed | -$386K | – | 2333 |
|
|
2019
Q4 | $386K | Sell |
13,189
-87,089
| -87% | -$2.07M | 0.01% | 1697 |
|
|
2019
Q3 | $1.92M | Sell |
100,278
-30,319
| -23% | -$711K | 0.04% | 645 |
|
|
2019
Q2 | $2.87M | Buy |
130,597
+102,105
| +358% | +$2.24M | 0.05% | 519 |
|
|
2019
Q1 | $583K | Sell |
28,492
-98,636
| -78% | -$1.71M | 0.02% | 1084 |
|
|
2018
Q4 | $1.6M | Buy |
127,128
+124,881
| +5,558% | +$1.86M | 0.08% | 375 |
|
|
2018
Q3 | $34K | Sell |
2,247
-10,775
| -83% | -$149K | ﹤0.01% | 1753 |
|
|
2018
Q2 | $171K | Buy |
+13,022
| New | +$143K | 0.01% | 1406 |
|
|
2016
Q3 | – | Sell |
-50,955
| Closed | -$410K | – | 1803 |
|
|
2016
Q2 | $410K | Buy |
50,955
+33,329
| +189% | +$267K | 0.02% | 895 |
|
|
2016
Q1 | $119K | Sell |
17,626
-51,933
| -75% | -$342K | 0.01% | 1361 |
|
|
2015
Q4 | $547K | Buy |
+69,559
| New | +$509K | 0.03% | 784 |
|
|
2015
Q1 | – | Sell |
-19,554
| Closed | -$82K | – | 2017 |
|
|
2014
Q4 | $82K | Buy |
+19,554
| New | +$89.9K | ﹤0.01% | 1726 |
|
Other funds holding NEO
FLAM
GF
DM
Cubist Systematic Strategies's NEO Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its NeoGenomics (NEO) stake by 92% in Q3 2025, selling an estimated $5.34M and leaving 67,958 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.
Cubist Systematic Strategies first reported a position in NEO in Q4 2014 and has held it in 26 quarters since. The position peaked at $6.07M in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.
- Cubist Systematic Strategies held 67,958 shares of NeoGenomics worth $525K as of Q3 2025.
- Cubist Systematic Strategies sold 762,547 NeoGenomics shares in Q3 2025, an estimated $5.34M.
- NeoGenomics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2261 holding.
- Cubist Systematic Strategies first reported a position in NeoGenomics in Q4 2014 and has held it in 26 quarters since.
- Cubist Systematic Strategies's NeoGenomics position peaked at $6.07M in Q2 2025.
- 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.